Literature DB >> 22751108

New insights into the mechanisms of venous thrombosis.

Nigel Mackman1.   

Abstract

Venous thrombosis is a leading cause of morbidity and mortality in industrialized countries, especially in the elderly. Many risk factors have been identified for venous thrombosis that alter blood flow, activate the endothelium, and increase blood coagulation. However, the precise mechanisms that trigger clotting in large veins have not been fully elucidated. The most common site for initiation of the thrombus appears to be the valve pocket sinus, due to its tendency to become hypoxic. Activation of endothelial cells by hypoxia or possibly inflammatory stimuli would lead to surface expression of adhesion receptors that facilitate the binding of circulating leukocytes and microvesicles. Subsequent activation of the leukocytes induces expression of the potent procoagulant protein tissue factor that triggers thrombosis. Understanding the mechanisms of venous thrombosis may lead to the development of new treatments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22751108      PMCID: PMC3386811          DOI: 10.1172/JCI60229

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  112 in total

1.  Increasing trends in waist circumference and abdominal obesity among US adults.

Authors:  Chaoyang Li; Earl S Ford; Lisa C McGuire; Ali H Mokdad
Journal:  Obesity (Silver Spring)       Date:  2007-01       Impact factor: 5.002

2.  Polyphosphate modulates blood coagulation and fibrinolysis.

Authors:  Stephanie A Smith; Nicola J Mutch; Deepak Baskar; Peter Rohloff; Roberto Docampo; James H Morrissey
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-12       Impact factor: 11.205

3.  Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.

Authors:  Andra H James; Margaret G Jamison; Leo R Brancazio; Evan R Myers
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

Review 4.  Deep vein thrombosis.

Authors:  Paul A Kyrle; Sabine Eichinger
Journal:  Lancet       Date:  2005 Mar 26-Apr 1       Impact factor: 79.321

5.  Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation.

Authors:  Christian Kannemeier; Aya Shibamiya; Fumie Nakazawa; Heidi Trusheim; Clemens Ruppert; Philipp Markart; Yutong Song; Eleni Tzima; Elisabeth Kennerknecht; Michael Niepmann; Marie-Luise von Bruehl; Daniel Sedding; Steffen Massberg; Andreas Günther; Bernd Engelmann; Klaus T Preissner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

Review 6.  Tissue-specific hemostasis in mice.

Authors:  Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

7.  Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice.

Authors:  M Monetti; M Canavesi; M Camera; R Parente; R Paoletti; E Tremoli; A Corsini; S Bellosta
Journal:  Pharmacol Res       Date:  2007-02-12       Impact factor: 7.658

8.  Microparticle-associated tissue factor activity: a link between cancer and thrombosis?

Authors:  M E T Tesselaar; F P H T M Romijn; I K Van Der Linden; F A Prins; R M Bertina; S Osanto
Journal:  J Thromb Haemost       Date:  2006-12-13       Impact factor: 5.824

Review 9.  Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets.

Authors:  Ben Atkinson; Karen Dwyer; Keiichi Enjyoji; Simon C Robson
Journal:  Blood Cells Mol Dis       Date:  2006-02-13       Impact factor: 3.039

10.  Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting.

Authors:  Liam Smeeth; Claire Cook; Sara Thomas; Andrew J Hall; Richard Hubbard; Patrick Vallance
Journal:  Lancet       Date:  2006-04-01       Impact factor: 79.321

View more
  98 in total

1.  The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran.

Authors:  Mohammadreza Amirsadri; Sarah Mousavi; Ali Karimipour
Journal:  Daru       Date:  2019-07-31       Impact factor: 3.117

2.  Gain in translation: heme oxygenase-1 induced by activated protein C promotes thrombus resolution.

Authors:  H Deguchi; D J Elias; J H Griffin
Journal:  J Thromb Haemost       Date:  2014-01       Impact factor: 5.824

3.  A computational model based on fibrin accumulation for the prediction of stasis thrombosis following flow-diverting treatment in cerebral aneurysms.

Authors:  Chubin Ou; Wei Huang; Matthew Ming-Fai Yuen
Journal:  Med Biol Eng Comput       Date:  2016-04-22       Impact factor: 2.602

4.  Biological properties of extracellular vesicles and their physiological functions.

Authors:  María Yáñez-Mó; Pia R-M Siljander; Zoraida Andreu; Apolonija Bedina Zavec; Francesc E Borràs; Edit I Buzas; Krisztina Buzas; Enriqueta Casal; Francesco Cappello; Joana Carvalho; Eva Colás; Anabela Cordeiro-da Silva; Stefano Fais; Juan M Falcon-Perez; Irene M Ghobrial; Bernd Giebel; Mario Gimona; Michael Graner; Ihsan Gursel; Mayda Gursel; Niels H H Heegaard; An Hendrix; Peter Kierulf; Katsutoshi Kokubun; Maja Kosanovic; Veronika Kralj-Iglic; Eva-Maria Krämer-Albers; Saara Laitinen; Cecilia Lässer; Thomas Lener; Erzsébet Ligeti; Aija Linē; Georg Lipps; Alicia Llorente; Jan Lötvall; Mateja Manček-Keber; Antonio Marcilla; Maria Mittelbrunn; Irina Nazarenko; Esther N M Nolte-'t Hoen; Tuula A Nyman; Lorraine O'Driscoll; Mireia Olivan; Carla Oliveira; Éva Pállinger; Hernando A Del Portillo; Jaume Reventós; Marina Rigau; Eva Rohde; Marei Sammar; Francisco Sánchez-Madrid; N Santarém; Katharina Schallmoser; Marie Stampe Ostenfeld; Willem Stoorvogel; Roman Stukelj; Susanne G Van der Grein; M Helena Vasconcelos; Marca H M Wauben; Olivier De Wever
Journal:  J Extracell Vesicles       Date:  2015-05-14

5.  The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women.

Authors:  Laura B Harrington; Marc Blondon; Mary Cushman; Andrew M Kaunitz; Jacques E Rossouw; Matthew A Allison; Lisa W Martin; Karen C Johnson; Jan Rosing; Nancy F Woods; Andrea Z LaCroix; Susan R Heckbert; Barbara McKnight; Nicholas L Smith
Journal:  Menopause       Date:  2017-04       Impact factor: 2.953

6.  Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice.

Authors:  Mitchell R Dyer; Wyeth Alexander; Adnan Hassoune; Qiwei Chen; Tomasz Brzoska; Jurgis Alvikas; Yingjie Liu; Shannon Haldeman; Will Plautz; Patricia Loughran; Hui Li; Brian Boone; Yoel Sadovsky; Prithu Sundd; Brian S Zuckerbraun; Matthew D Neal
Journal:  J Thromb Haemost       Date:  2019-07-28       Impact factor: 5.824

Review 7.  Statins as a preventative therapy for venous thromboembolism.

Authors:  Alex Wallace; Hassan Albadawi; Peter Hoang; Andrew Fleck; Sailendra Naidu; Grace Knuttinen; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

8.  Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.

Authors:  Konstantin Stark; Vanessa Philippi; Sven Stockhausen; Johanna Busse; Antonella Antonelli; Meike Miller; Irene Schubert; Parandis Hoseinpour; Sue Chandraratne; Marie-Luise von Brühl; Florian Gaertner; Michael Lorenz; Alessandra Agresti; Raffaele Coletti; Daniel J Antoine; Ralf Heermann; Kirsten Jung; Sven Reese; Iina Laitinen; Markus Schwaiger; Axel Walch; Markus Sperandio; Peter P Nawroth; Christoph Reinhardt; Sven Jäckel; Marco E Bianchi; Steffen Massberg
Journal:  Blood       Date:  2016-08-29       Impact factor: 22.113

Review 9.  New players in haemostasis and thrombosis.

Authors:  Julia E Geddings; Nigel Mackman
Journal:  Thromb Haemost       Date:  2014-02-27       Impact factor: 5.249

10.  Direct oral anticoagulant treatment of deep vein thrombosis reduces IL-6 expression in peripheral mono-nuclear blood cells.

Authors:  Saverio Candido; Giovanni Lumera; Giuliana Barcellona; Davide Vetri; Elda Tumino; Ingrid Platania; Evelise Frazzetto; Graziella Privitera; Carmela Incognito; Agostino Gaudio; Salvatore Santo Signorelli
Journal:  Exp Ther Med       Date:  2020-10-21       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.